Status:
UNKNOWN
Microfracture vs. Microfracture and BMAC for Osteochondral Lesions of the Talus
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Osteochondral Lesion of Talus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Osteochondral lesions of the talus are thought to be due in large part to traumatic events or repetitive microtrauma that causes damage to both the articular cartilage and the subchondral bone. There ...
Eligibility Criteria
Inclusion
- Greater than 18 years of age and scheduled for surgery to treat osteochondral lesion of the talus Able and willing to sign informed consent document
Exclusion
- Unwilling to sign informed consent document
Key Trial Info
Start Date :
October 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03856021
Start Date
October 18 2018
End Date
October 1 2020
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Institute
Philadelphia, Pennsylvania, United States, 19107